يعرض 1 - 10 نتائج من 47 نتيجة بحث عن '"Michael H. Kagey"', وقت الاستعلام: 0.82s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Validation of a DKK1 RNAscope chromogenic in situ hybridization assay for gastric and gastroesophageal junction adenocarcinoma tumors

    المؤلفون: Charles Caldwell, James B. Rottman, Will Paces, Elizabeth Bueche, Sofia Reitsma, Joseph Gibb, Vitria Adisetiyo, Michael S. Haas, Heidi Heath, Walter Newman, Jason Baum, Roberto Gianani, Michael H. Kagey

    المصدر: Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)

    مصطلحات موضوعية: Medicine, Science

    وصف الملف: electronic resource

    العلاقة: https://doaj.org/toc/2045-2322Test

    الوصول الحر: https://doaj.org/article/386bfb9934384f32ac9a8bd2228acb37Test

    View record in DOAJ النص الكامل

    أضف إلى المفضلة
  2. 2
    DKK1 is a predictive biomarker for response to DKN-01: Results of a phase 2 basket study in women with recurrent endometrial carcinoma

    المؤلفون: Rebecca Arend, Jhalak Dholakia, Cesar Castro, Ursula Matulonis, Erika Hamilton, Camille Gunderson Jackson, Kristopher LyBarger, Howard M. Goodman, Linda R. Duska, Haider Mahdi, Adam C. ElNaggar, Michael H. Kagey, Amy Liu, Diane Piper, Lisa M. Barroilhet, William Bradley, Jasgit Sachdev, Cynthia A. Sirard, David M. O'Malley, Michael Birrer

    المصدر: Gynecologic Oncology. 172:82-91

    مصطلحات موضوعية: Oncology, Obstetrics and Gynecology

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::3119dea5b8a715375b4afd1711f2bd14Test
    https://doi.org/10.1016/j.ygyno.2023.03.013Test


    أضف إلى المفضلة
  3. 3
    DKK1 drives immune suppressive phenotypes in intrahepatic cholangiocarcinoma and can be targeted with anti‐DKK1 therapeutic DKN ‐01

    المؤلفون: Edward J. Jarman, Marta Horcas‐Lopez, Scott H. Waddell, Stephanie MacMaster, Konstantinos Gournopanos, Daniel Y. H. Soong, Kamila I. Musialik, Panagiota Tsokkou, Minn‐E Ng, William A. Cambridge, David H. Wilson, Michael H. Kagey, Walter Newman, Jeffrey W. Pollard, Luke Boulter

    المصدر: Jarman, E, Horcas Lopez, M, Waddell, S, MacMaster, S, Gournopanos, K, Soong, D, I. Musialik, K, Tsokkou, P, Ng, M-E, Cambridge, W, Wilson, D, Kagey, M H, Newman, W, Pollard, J W & Boulter, L 2022, ' DKK1 drives immune suppressive phenotypes in intrahepatic cholangiocarcinoma and can be targeted with anti-DKK1 therapeutic DKN-01 ', Liver International . https://doi.org/10.1111/liv.15383Test

    مصطلحات موضوعية: Cholangiocarcinoma, Dickkopf-1, Hepatology, Immune Tolerance, Macrophage Activation, Regulatory T Cell

    وصف الملف: application/vnd.openxmlformats-officedocument.wordprocessingml.document; application/pdf

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::668e3173330f4883253652784be38a86Test
    https://doi.org/10.1111/liv.15383Test


    أضف إلى المفضلة
  4. 4
    Figure S7 from mDKN-01, a Novel Anti-DKK1 mAb, Enhances Innate Immune Responses in the Tumor Microenvironment

    المؤلفون: Walter Newman, James B. Rottman, Franziska Schuerpf, Heidi Heath, Michael H. Kagey, Michael S. Haas

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83f5dcc61b20a2fcad95448da894c3a8Test
    https://doi.org/10.1158/1541-7786.22526999.v1Test


    أضف إلى المفضلة
  5. 5
    Data from mDKN-01, a Novel Anti-DKK1 mAb, Enhances Innate Immune Responses in the Tumor Microenvironment

    المؤلفون: Walter Newman, James B. Rottman, Franziska Schuerpf, Heidi Heath, Michael H. Kagey, Michael S. Haas

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::2a770e7b3842bd86663344e6274479bfTest
    https://doi.org/10.1158/1541-7786.c.6545285.v1Test


    أضف إلى المفضلة
  6. 6
    Table S1 from mDKN-01, a Novel Anti-DKK1 mAb, Enhances Innate Immune Responses in the Tumor Microenvironment

    المؤلفون: Walter Newman, James B. Rottman, Franziska Schuerpf, Heidi Heath, Michael H. Kagey, Michael S. Haas

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8268e99cc05723647b3b14ef9eaaafb1Test
    https://doi.org/10.1158/1541-7786.22526996Test


    أضف إلى المفضلة
  7. 7
    Data from Phase I and Biomarker Study of the Wnt Pathway Modulator DKN-01 in Combination with Gemcitabine/Cisplatin in Advanced Biliary Tract Cancer

    المؤلفون: Dan G. Duda, Andrew X. Zhu, Devalingam Mahalingam, Rebecca Miksad, Alok A. Khorana, Thomas A. Abrams, Gulam A. Manji, Anthony B. El-Khoueiry, Stacey Stein, Jennifer R. Eads, Michael H. Kagey, Michael Schrag, Cynthia Sirard, Lipika Goyal

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3acc2e0adf4f209458f9bd53a8d231f5Test
    https://doi.org/10.1158/1078-0432.c.6529550.v1Test


    أضف إلى المفضلة
  8. 8
    Methods and Tables S1-S3 from Phase I and Biomarker Study of the Wnt Pathway Modulator DKN-01 in Combination with Gemcitabine/Cisplatin in Advanced Biliary Tract Cancer

    المؤلفون: Dan G. Duda, Andrew X. Zhu, Devalingam Mahalingam, Rebecca Miksad, Alok A. Khorana, Thomas A. Abrams, Gulam A. Manji, Anthony B. El-Khoueiry, Stacey Stein, Jennifer R. Eads, Michael H. Kagey, Michael Schrag, Cynthia Sirard, Lipika Goyal

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::189c3a90ac5930ea842b4b08064234ffTest
    https://doi.org/10.1158/1078-0432.22476995.v1Test


    أضف إلى المفضلة
  9. 9
    Safety, Efficacy, and Biomarker Results from a Phase Ib Study of the Anti-DKK1 Antibody DKN-01 in Combination with Pembrolizumab in Advanced Esophagogastric Cancers

    المؤلفون: John H. Strickler, Johanna C. Bendell, Samuel J. Klempner, James B. Rottman, Michael H. Kagey, Stacey Stein, Girish S. Naik, Marya F. Chaney, Victoria M. Villaflor, Laura LaNiel Tenner, Cynthia A. Sirard

    المصدر: Molecular Cancer Therapeutics. 20:2240-2249

    مصطلحات موضوعية: Adult, Male, Oncology, Cancer Research, medicine.medical_specialty, Esophageal Neoplasms, Mrna expression, Programmed Cell Death 1 Receptor, Pembrolizumab, Antibodies, Monoclonal, Humanized, Stomach Neoplasms, Esophagogastric cancer, Internal medicine, Biomarkers, Tumor, medicine, Humans, Aged, Predictive biomarker, Aged, 80 and over, biology, business.industry, Middle Aged, Acquired immune system, DKK1, biology.protein, Biomarker (medicine), Female, Antibody, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d57089086b532fd1a3579ca7fe1a764cTest
    https://doi.org/10.1158/1535-7163.mct-21-0273Test


    أضف إلى المفضلة
  10. 10
    mDKN-01, a Novel Anti-DKK1 mAb, Enhances Innate Immune Responses in the Tumor Microenvironment

    المؤلفون: Heidi Heath, Michael Haas, Michael H. Kagey, Walter Newman, James B. Rottman, Franziska Schuerpf

    المصدر: Molecular Cancer Research. 19:717-725

    مصطلحات موضوعية: 0301 basic medicine, Cancer Research, Pembrolizumab, Mice, 03 medical and health sciences, 0302 clinical medicine, Immune system, Neoplasms, Tumor Microenvironment, medicine, Animals, Humans, Molecular Biology, Tumor microenvironment, Innate immune system, biology, business.industry, Melanoma, Antibodies, Monoclonal, Cancer, medicine.disease, Metastatic breast cancer, Immunity, Innate, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Cancer research, biology.protein, Intercellular Signaling Peptides and Proteins, Antibody, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ff1212be4303ae0d32d7b43ff110725Test
    https://doi.org/10.1158/1541-7786.mcr-20-0799Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث